Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Convalescent plasma Emergency use authorization Experimental Antiviral Jan/15/2021 27 5
Ivermectin Potential treatment - clinical evidence Used to treat other disease Antiviral Jan/15/2021 12 0
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Dec/22/2020 24 5
Sofosbuvir Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/18/2020 6 5
Ritonavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Dec/09/2020 21 11
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Nov/26/2020 22 11
Interferon beta-1a Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/12/2020 2 1
Heparin Potential treatment - clinical evidence Used to treat other disease Antiviral Nov/10/2020 11 1
Glycyrrhizin Potential treatment - theoretical effect Natural product Antiviral May/31/2020 1 0
Phenyl isothiocyanate Potential treatment - pre-clinical evidence Experimental Antiviral May/29/2020 1 0